PO2 measurement using positronium in PET for hypoxia imaging

During a PET scan, ca. 100 billion 'nano-size oxygen-meters' are spontaneously created and annihilated in the human body, and the name of the oxygen-meter is positronium. Here we show how to read these oxygen-meters as a new methodology for hypoxia imaging.
Published in Cancer
PO2 measurement using positronium in PET for hypoxia imaging
Like

'The output is the same, but the timing is not'.

(keywords: oncology, radiology, nuclear medicine, medical physics, PET, hypoxia, 44Sc)

The output from a patient in the positron emission tomography (PET) is the annihilation γ-ray photons emitted according to the following equation:

First, the radioactive isotope, e.g. 18F, undergoes the β+ decay and emits a positron (e+). Second, the positron collides with an electron (e) in surrounding molecules. Last, the positron and electron annihilate into 2 γ-ray photons due to the matter-antimatter pair annihilation. This is the conventional picture; however, it should be modified to include the positronium (Ps) as described in the lower part of the equation. Ps is a hydrogen-like atom consisting of a positron and an electron and the atom decays into 2 γ-ray photons within a short time: ca. 2 ns (1/500,000,000 s) on average in vivo. 'The output (2γ) is the same' is a reason why Ps has received little attention in PET; however, ca. 100 billion Ps atoms are spontaneously created and annihilated in the human body per examination.

'But the timing is not' is the reason why the Ps can provide new biological information on hypoxia. The emission of the output (2γ) is delayed as long as the lifetime of Ps, and the lifetime is influenced considerably by the partial pressure of oxygen (pO2) because the annihilation of Ps is accelerated by O2 due to the unpaired electrons.

The figure below shows the relation between pO2 in water and Ps annihilation rate (Γ), which is the inverse of the lifetime. Linearity is observed because the chance for Ps to encounter O2 for quenching is proportional to pO2, and the line and its equation in the figure describe how to convert Γ into pO2. The sensitivity can be estimated from the uncertainties of the equation to be ca. 10 mmHg when 300 million counts are obtained from the field-of-view (FOV) and to be ca. 5 mmHg when 1 billion counts are obtained. According to previous reports, pO2 in healthy liver tissue cells is ca. 41 mmHg [1] and that in liver tumour cells is ca. 6 mmHg [2]; therefore, Ps has enough sensitivity for discriminating the tumour hypoxia region from the control regions.

Figure: The relation between pO2/mmHg and Ps annihilation rate (Γ/μs-1), which is the inverse of the lifetime. The parentheses in the equation indicate the uncertainty (1σ). 

The advantage of this method is the absolute determination of pO2 independently of the scanner and protocol. As this method is based on the fundamental properties of Ps, i.e. the spin and reactions, the results are also independent of the mechanism of the delivery/accumulation of the radiopharmaceuticals. The technical barriers related to the hardware are expected not high because the required specifications of a new timer for measuring the lifetime of Ps is comparable with that of the time-of-flight (TOF) function installed in current scanners. However, the development of radiopharmaceuticals with an appropriate radioactive isotope having a relatively short half-life, i.e. several hours/days, and a prompt-γ-ray emission, such as 44Sc [3], is essential for the clinical use.

References

  1. Carreau, A. et al. Why is the partial oxygen pressure of human tissues a crucial parameter? Small molecules and hypoxia. J. Cell. Mol. Med. 15, 1239–1253 (2011). (DOI: 10.1111/j.1582-4934.2011.01258.x)
  2. Vaupel, P. et al. Detection and characterization of tumour hypoxia using pO2 histography. Antioxid. Redox Signal. 9, 1221–1225 (2007). (DOI: 10.1089/ars.2007.1628)
  3. Müller, C. et al. Scandium and terbium radionuclides for radiotheranostics: current state of development towards clinical application. Brit. J. Radiol. 91, 20180074 (2018). (DOI: 10.1259/bjr.20180074)
  4. Shibuya, K., et al. Oxygen sensing ability of positronium atom for tumour hypoxia imaging. Communications Physics 3, 173 (2020). (DOI: 10.1038/s42005-020-00440-z, OPEN ACCESS)
  5. Devor, C. Timing the life of antimatter particles may lead to better cancer treatment. UTokyo Focus (2020). (https://www.u-tokyo.ac.jp/focus/en/press/z0508_00133.html)
  6. Stephens, M. Positronium formed during PET scans could detect hypoxic tumours. Physics World (2020). (https://physicsworld.com/a/positronium-formed-during-pet-scans-could-detect-hypoxic-tumours/)

This work [4] was published on 1 October 2020, in Communication Physics, a sister journal of Nature Communications and Communications Biology. You can find general commentaries in the press release from the University of Tokyo by Ms Caitlin Devor [5] and in a magazine from the Institute of Physics (IOP, England), i.e. Physics World, by Mr Marric Stephens [6]. Reading them would assist with the understanding of the original paper [4].

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in

Subscribe to the Topic

Cancer Biology
Life Sciences > Biological Sciences > Cancer Biology

Related Collections

With collections, you can get published faster and increase your visibility.

Quantum simulation of gauge theories: steps and strides

This focus collection captures a slice of current progress and perspectives---deepening the understanding of gauge theory quantum simulation, broadly defined, and driving the community toward large-scale quantum simulations of gauge theories.

Publishing Model: Open Access

Deadline: Apr 24, 2024

Ultrafast X-ray Spectroscopy

This collection aims to provide a description of the state-of-the-art in time-resolved X-ray spectroscopic measurements, including applications, technological developments and theoretical studies to explore ultrafast phenomena in isolated quantum systems.

Publishing Model: Open Access

Deadline: May 13, 2024